drugset / Trial / NCT03447821
Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the safety and the preliminary efficacy data on the three doses of the new Cosmo Technologies oral rifamycin SV colon-release 200 mg tablets manufactured according to MMX technology (CB-01-11) in the treatment of infectious diarrhoea.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rifamycin SV | Unknown | 400 mg | Oral |
| Comparator | Rifamycin SV | Unknown | 800 mg | Oral |
| Comparator | Rifamycin SV | Unknown | 1200 mg | Oral |